We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





New, Fast, Portable Saliva Screening Test Uses Infrared Light Technology to Confirm SARS-CoV-2 Infection

By LabMedica International staff writers
Posted on 31 May 2021
Print article
Image: This transmission electron microscope image shows SARS-CoV-2, also known as 2019-nCoV (Photo courtesy of NIAID)
Image: This transmission electron microscope image shows SARS-CoV-2, also known as 2019-nCoV (Photo courtesy of NIAID)
International research has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.

The new diagnostic approach involving the use of a portable infrared instrument to detect the SARS-CoV-2 virus in saliva, was led by scientists at Monash University (Melbourne, Australia) and the Peter Doherty Institute for Infection and Immunity (Melbourne, Australia) and could pave the way for safer and more efficient COVID-19 testing.

The team identified a signature of the infectious agent in the infrared spectra of saliva from 27 out of the 29 SARS-CoV-2-infected human subjects with COVID-19-like symptoms. The scientists say this is very encouraging preliminary research and are keen to see further testing with a larger patient cohort to better understand the specificity of this approach. A portable infrared spectrometer was modified to enable high throughput screening enabling the samples to be rapidly scanned in a contactless mode without having to clean the instrument between measurements.

The researchers estimate that this technique could be capable of screening 5000 samples per day per instrument, with results for each sample being ready in five minutes. Because the infrared light interacted with the vibrations of molecules, it could be used to generate a spectrum that represented a unique chemical fingerprint of the sample that was then processed using machine learning algorithms. The proposed new test also avoids the discomfort associated with nasopharyngeal swabs, an advantage that could improve community participation in testing.

A similar infrared technique known as Attenuated Total Reflectance (ATR) spectroscopy has previously been used by the Monash researchers to detect malaria and hepatitis. The new transflection infrared based approach offers triple the absorbance and hence interrogates more saliva to detect pathogens compared to the traditional ATR technology. The speed and versatility of the technique potentiates its use for point-of-care screening at airports, sporting venues, universities or schools, to triage patients for RT-PCR testing.

“The most significant advantages of using this infrared-based technology on saliva samples, include the speed and ease with which the test can be performed, its affordability and the reduced risk to both patients and healthcare workers,” said Professor Bayden Wood from the Monash University School of Chemistry.

“The approach has significant advantages over the standard Real Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) that is the current gold standard for detection,” said Professor Dale Godfrey from the Doherty Institute. “As we know, this requires that samples are sent to a dedicated laboratory and results take a day or more”.

“A person can contribute the sample by simply dribbling into a sterile container,” said Professor Damian Purcell from the Doherty Institute. “The result can be derived in less than five minutes and a rapid result minimizes the delay in determining if quarantine is required, therefore minimizing the risk of further spread of infection.”

Related Links:
Monash University
Peter Doherty Institute for Infection and Immunity


Gold Member
COVID-19 Rapid Test
AQ+ COVID-19 Ag Rapid Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay
New
Thyroxine ELISA
T4 ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.